Cytokines, endothelial dysfunction, and insulin resistance

• Published in: Arquivos brasileiros de endocrinologia e metabologia Vol. 50; no. 2; pp. 304 - 312
• Main Authors: de Carvalho, Maria Helena C, Colaço, André Luiz, Fortes, Zuleica Bruno
• Format: Journal Article
• Language: Portuguese
• Published: Brazil 01-04-2006
• Subjects: Adiponectin - physiology; Cardiovascular Diseases - etiology; Cytokines - physiology; Endothelium, Vascular - physiopathology; Fatty Acids - physiology; Humans; Hypertension - complications; Inflammation - metabolism; Insulin Resistance - physiology; Leptin - physiology
• ISSN: 0004-2730

Endothelial dysfunction is associated with several vascular conditions as atherosclerosis, hypertension, hyperlipidemia and diabetes mellitus. In all these conditions insulin resistance (IR) is present. Cytokines are low molecular weight proteins with several endocrine and metabolic functions that participate of inflammation and immune response. Several of these cytokines are independent risk factors for cerebrovascular and coronary artery disease. The major sources of cytokines (adipokines) are the visceral and subcutaneous adipose tissues. Thus, increased adipose tissue mass is associated with alteration in adipokine production as over expression of tumor necrosis factor alpha, interleukin 6, plasminogen activator inhibitor 1, and under expression of adiponectin in adipocite tissue. The pro-inflammatory status associated with these changes provides a potential link between IR and endothelial dysfunction, the early stage in the atherosclerotic process, in obese individuals, and type 2 diabetic patients. Reduction of adipose tissue mass through weight reduction in association with exercise reduces TNF-alpha, IL-6, and PAI-1, increases adiponectin, and is associated with improved insulin sensitivity and endothelial function. This review will focus on the evidence for regulation of endothelial function by insulin and the adypokines such as adyponectin, leptin, resistin, IL-6 and TNF-alpha. Interaction between insulin signaling and adypokines will be discussed, as well as the concept that aberrant adypokine secretion in IR and/or obesity impairs endothelial function and contributes further to reduce insulin sensitivity.